<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><id>http://publicationslist.org/data/a.ganci/atom.xml</id><title>Antonella Ganci's Publications List</title>
<link rel="self" type="application/atom+xml" href="http://publicationslist.org/data/a.ganci/atom.xml"/><link rel="alternate" type="text/html" href="http://publicationslist.org/a.ganci"/><author><name>Antonella Ganci</name><uri>http://publicationslist.org/a.ganci</uri></author><icon>$basepathfavicon.ico</icon><subtitle>Recent additions to Antonella Ganci's PublicationsList.org page</subtitle><logo>http://publicationslist.org/publications.png</logo><updated>2010-01-27T14:35:13Z</updated>

<entry>
<id>http://publicationslist.org/a.ganci/refid1</id>
<updated>2010-01-25T13:26:03Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid1'/>
<title type='html'>Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.</title>
<summary type='html'>Summary Background: Chronic hyperglycemia is a major contributor to in vivo platelet activation in diabetes mellitus. Objectives: We aimed at evaluating the effects of acarbose, an alpha-glucosidase inhibitor, on platelet activation and its determinants in newly-diagnosed type 2 diabetic patients. Methods: Forty-eight subjects (26 M, aged 61+/-8 yr) with early type 2 diabetes (baseline HbA(1c)&lt;/= ...&lt;br/&gt;&lt;br/&gt;F Santilli, G Formoso, P Sbraccia, M Averna, R Miccoli, P Di Fulvio, A Ganci, N Pulizzi, S Lattanzio, G Ciabattoni, A Consoli, R Lauro, C Patrono, G Davì (2010)  &lt;i&gt;J Thromb Haemost&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; :  &lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid2</id>
<updated>2010-01-25T13:26:03Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid2'/>
<title type='html'>Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity.</title>
<summary type='html'>Relapses of hyperthyroidism after treatment with radioiodine for uni- or multi-nodular goiter may be accompanied by the appearance of TSAb. However, this phenomenon has only emerged from one retrospective study on Northern European patients, in which it was not possible to determine whether TSAb also appeared in treated patients who did not relapse. The present study aimed to assess the appearance...&lt;br/&gt;&lt;br/&gt;N Custro, A Ganci, V Scafidi (2003)  &lt;i&gt;J Endocrinol Invest&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 26: 2 106-110&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid3</id>
<updated>2010-01-25T13:26:03Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid3'/>
<title type='html'>Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina.</title>
<summary type='html'>BACKGROUND: The evidence that inflammation plays a pivotal role in the pathophysiology of acute coronary syndromes prompted us to investigate the effects of glucocorticoid treatment on leukotriene (LT) C4 and thromboxane (TX) A2 biosynthesis in unstable angina. METHODS AND RESULTS: Urinary LTE4 and 11-dehydro-TXB2 were significantly higher in 12 patients with unstable angina than in 12 patients wi...&lt;br/&gt;&lt;br/&gt;Francesco Cipollone, Antonina Ganci, Anita Greco, Maria Rosaria Panara, Massimo Pasquale, Domenico Di Gregorio, Ettore Porreca, Andrea Mezzetti, Franco Cuccurullo, Paola Patrignani (2003)  &lt;i&gt;Circulation&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 107: 1 55-61&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid5</id>
<updated>2010-01-25T13:26:03Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid5'/>
<title type='html'>Determinants of enhanced thromboxane biosynthesis in renal transplantation.</title>
<summary type='html'>BACKGROUND: Despite great improvement in patient and graft survival, the long-term morbidity and mortality in renal transplant recipients (RTRs) are still significant, with a high incidence of cardiovascular disease-related deaths. METHODS: We investigated thromboxane (TXA2) biosynthesis and endothelial and coagulative activation in 65 patients who received a renal transplant. RESULTS: The rate of...&lt;br/&gt;&lt;br/&gt;M Averna, C M Barbagallo, A Ganci, C Giammarresi, A B Cefalù, V Sparacino, F Caputo, S Basili, A Notarbartolo, G Davì (2001)  &lt;i&gt;Kidney Int&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 59: 4 1574-1579&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid4</id>
<updated>2010-01-25T13:26:03Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid4'/>
<title type='html'>Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis.</title>
<summary type='html'>OBJECTIVES: This study aimed at investigating the respective impacts of virus-related chronic hepatitis (CH) and liver cirrhosis (LC) on glycemic homeostasis, with reference to grading and/or staging of liver disease and to contribution of the two main responsible viruses. MATERIAL AND METHODS: The glycometabolic features of 82 patients with CH (B-related 16, and C-related 66) and 145 with LC (B-r...&lt;br/&gt;&lt;br/&gt;N Custro, A Carroccio, A Ganci, V Scafidi, P Campagna, L Di Prima, G Montalto (2001)  &lt;i&gt;Diabetes Metab&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 27: 4 Pt 1 476-481&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid6</id>
<updated>2010-01-25T13:26:03Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid6'/>
<title type='html'>In vivo lipid peroxidation and platelet activation in cystic fibrosis.</title>
<summary type='html'>F(2)-isoprostanes are bioactive peroxidation products of arachidonic acid whose urinary excretion provides an index of lipid peroxidation in vivo. We tested the hypothesis that formation of F(2)-isoprostanes is altered in patients with cystic fibrosis and contributes to platelet activation and pulmonary dysfunction in this setting. The urinary excretion of immunoreactive 8-iso-prostaglandin F(2alp...&lt;br/&gt;&lt;br/&gt;G Ciabattoni, G Davì, M Collura, L Iapichino, F Pardo, A Ganci, R Romagnoli, J Maclouf, C Patrono (2000)  &lt;i&gt;Am J Respir Crit Care Med&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 162: 4 Pt 1 1195-1201&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid7</id>
<updated>2010-01-25T13:26:03Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid7'/>
<title type='html'>Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia.</title>
<summary type='html'>Thromboxane (Tx) A2 biosynthesis is enhanced in the majority of patients with type IIa hypercholesterolemia. Because blood clotting activation is an important component of the inflammatory response, involved in the initiation and progression of atherosclerotic plaques, we have investigated TxA2 biosynthesis, neutrophil activation and thrombin generation in 24 patients with type IIa hypercholestero...&lt;br/&gt;&lt;br/&gt;G Davì, A Ganci, M Averna, C Giammarresi, C Barbagallo, I Catalano, A Calà, A Notarbartolo (1995)  &lt;i&gt;Thromb Haemost&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 74: 4 1015-1019&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid8</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid8'/>
<title type='html'>Effects of nabumetone on prostanoid biosynthesis in humans.</title>
<summary type='html'>BACKGROUND: The active metabolite of the anti-inflammatory drug nabumetone has been characterized as a selective inhibitor of the inducible prostaglandin H synthase (PGHS). The aim of this study was to investigate the rate of eicosanoid biosynthesis after oral dosing with nabumetone in nine healthy subjects. METHODS: We measured the urinary excretion of products of platelet (11-dehydro-thromboxane...&lt;br/&gt;&lt;br/&gt;F Cipollone, A Ganci, M R Panara, A Greco, F Cuccurullo, C Patrono, P Patrignani (1995)  &lt;i&gt;Clin Pharmacol Ther&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 58: 3 335-341&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid12</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid12'/>
<title type='html'>Characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.</title>
<summary type='html'>P Patrignani, M R Panara, A Greco, O Fusco, C Natoli, S Iacobelli, F Cipollone, A Ganci, C Créminon, J Maclouf (1995)  &lt;i&gt;Adv Prostaglandin Thromboxane Leukot Res&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 23:  129-131&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid10</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid10'/>
<title type='html'>Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia.</title>
<summary type='html'>Thromboxane A2 (TXA2) biosynthesis is enhanced in the majority of patients with type IIa hypercholesterolemia. Because simvastatin (a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor) was previously shown to reduce platelet aggregation and TXB2 production ex vivo, we investigated TXA2 biosynthesis and platelet function in 24 patients with type IIa hypercholesterolemia randomized to receiv...&lt;br/&gt;&lt;br/&gt;A Notarbartolo, G Davì, M Averna, C M Barbagallo, A Ganci, C Giammarresi, F P La Placa, C Patrono (1995)  &lt;i&gt;Arterioscler Thromb Vasc Biol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 15: 2 247-251&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid11</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid11'/>
<title type='html'>Thromboxane biosynthesis and pulmonary function in cystic fibrosis.</title>
<summary type='html'>G Davì, L Iapichino, V Balsamo, A Ganci, C Giammarresi, P Patrignani, C Patrono (1995)  &lt;i&gt;Adv Prostaglandin Thromboxane Leukot Res&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 23:  369-371&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid9</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid9'/>
<title type='html'>Demonstration of Rickettsia Conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever.</title>
<summary type='html'>Endothelial injury in vivo induced by Rickettsia Conorii, the etiologic agent of Mediterranean Spotted Fever (MSF) has been recently demonstrated. We sought to determine whether platelet and/or coagulative activation in vivo can be demonstrated in the acute phase of MSF, through measurements of a major metabolite of thromboxane (TX) in the urine (11-dehydro-TXB2) and of plasma prothrombin fragment...&lt;br/&gt;&lt;br/&gt;G Davì, C Giammarresi, S Vigneri, A Ganci, C Ferri, L Di Francesco, G Vitale, S Mansueto (1995)  &lt;i&gt;Thromb Haemost&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 74: 2 631-634&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid13</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid13'/>
<title type='html'>Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.</title>
<summary type='html'>The aim of our study was to characterize a model of human prostaglandin endoperoxide synthase-2 (PGHS-2) expression allowing the assessment of pharmacological inhibition in vitro and ex vivo. Heparinized human whole blood samples were incubated with lipopolysaccharide (LPS, 0.1-50 micrograms/ml) for 0 to 24 hr at 37 degrees C. The contribution of platelet PGHS-1 was suppressed by either pretreatin...&lt;br/&gt;&lt;br/&gt;P Patrignani, M R Panara, A Greco, O Fusco, C Natoli, S Iacobelli, F Cipollone, A Ganci, C Créminon, J Maclouf (1994)  &lt;i&gt;J Pharmacol Exp Ther&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 271: 3 1705-1712&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid14</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid14'/>
<title type='html'>Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.</title>
<summary type='html'>Indobufen is a reversible inhibitor of platelet prostaglandin G/H-synthase. To verify the dose dependence of the antiplatelet effect of indobufen on ex vivo and in vivo indexes of thromboxane (TX) biosynthesis and TXA2-dependent platelet function, we studied nine patients with non-insulin-dependent diabetes mellitus (NIDDM). This was a randomized, double-blind, crossover study in which each patien...&lt;br/&gt;&lt;br/&gt;G Davì, C Patrono, I Catalano, N Custro, C Giammarresi, A Ganci, F Cosentino, A Notarbartolo (1993)  &lt;i&gt;Arterioscler Thromb&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 13: 9 1346-1349&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/a.ganci/refid15</id>
<updated>2010-01-25T13:27:15Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/a.ganci#refid15'/>
<title type='html'>Increased thromboxane biosynthesis in type IIa hypercholesterolemia.</title>
<summary type='html'>BACKGROUND. Increased platelet thromboxane (TX)A2 production has been described in type IIa hypercholesterolemia. To verify the relevance of these capacity-related measurements to the actual rate of TXA2 biosynthesis in vivo, we studied the urinary excretion of its major enzymatic metabolites in 46 patients with type IIa hypercholesterolemia and 20 age-matched controls. METHODS AND RESULTS. Urinar...&lt;br/&gt;&lt;br/&gt;G Davì, M Averna, I Catalano, C Barbagallo, A Ganci, A Notarbartolo, G Ciabattoni, C Patrono (1992)  &lt;i&gt;Circulation&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 85: 5 1792-1798&lt;br/&gt;</summary>
</entry>
</feed>
